INTRACT PHARMA
Intract Pharma Limited is an oral drug delivery licensing and product development company offering a range of proprietary formulation technologies to deliver novel and optimised therapeutics targeted to patient needs. The company is a spin-out of University College London, and is centred around over 15 years of research and innovation from the laboratory of Professor Abdul Basit. Intract's range of formulation technologies includes Phloral™ for colon targeted delivery, and ProRelease™, a versatile microparticulate delivery system. Complementary to these, Intract has developed unique gastrointestinal (GI) models, which closely reflect the physiological environment of the human GI tract, enabling accurate and predictable in vitro-in vivo correlation.
INTRACT PHARMA
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2016-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.intractpharma.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0)20 7691 4918
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Domain Not Resolving Microsoft Exchange Online IPv6 PHP Cloudflare Hosting Cloudflare DNS
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Core Biogenesis
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
Founder
Investors List
UCLB
UCLB investment in Seed Round - Intract Pharma
Official Site Inspections
http://www.intractpharma.com Semrush global rank: 8.67 M Semrush visits lastest month: 272
- Host name: 172.67.136.141
- IP address: 172.67.136.141
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
